This analysis finds that treatment for opiate addiction lowers health care costs, and reduces the likelihood of rearrest or conviction. The overall cost offset of medical, mental health, and long-term care relative to the cost for providing chemical dependency treatment is substantial for clients addicted to opiates, regardless of the type of treatment. These cost offsets averaged -$732 per person per month for methadone treatment, and -$541 per person per month for non-methadone treatment. These monthly savings are much higher than the cost offsets associated with providing substance abuse treatment for those dependent on other substances, which average -$276 per person. The findings are drawn from a longitudinal study of 16,034 clients who received Supplemental Security Income (SSI) benefits at some time between July 1997 and December 2001.
Report and/or Additional Information:
Related Publications:
- Bringing Recovery into Diverse Groups through Engagement and Support (4.97)
- Characteristics of Public Housing Assistance Recipients in Washington State (11.223)
- Drug Court Participants: Recidivism and Key Outcome Measures (4.99)
- Drug Court Participants: Recidivism and Key Outcome Measures (4.109)
- Geographic Distribution of Patients in Washington State’s Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project (9.114)
- Identifying Substance Use and Mental Health Disorders Using an SBIRT Model: Washington State's Experience (11.242)
- Sustainability of Screening, Brief Intervention, and Referral to Treatment in Healthcare Settings (4.101)
- Treatment of Stimulant Addiction Including Addiction to Methamphetamine Results in Lower Health Care Costs and Reduced Arrests and Convictions (11.114fs)
- Washington State Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project: Year One Performance (4.96)
- Washington State SBIRT Primary Care Integration: Implementation (4.98)
- Washington State’s Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project – Preliminary Outcomes through Year Two (4.102)